Category: Pharma

Industry, News, Pharma

Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for BPX-01 and BPX-04

September 15, 2020

Via: BioSpace

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced that it has received a formal notice of allowance from the U.S. Patent […]

Industry, Pharma

Drug Targets Identified More Discerningly

September 1, 2020

Via: Genetic Engineering and Biotechnology News

Experimental drugs face steep odds. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), out of every 5,000 to 10,000 compounds that enter the discovery and development pipeline, just 5 enter clinical trials, and only 1 receives approval. Other […]

Industry, Pharma

Phio Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update

August 12, 2020

Via: BioSpace

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today reported its financial results for the quarter ended June 30, 2020 and provided a business […]

Clinical Trials, Industry, Pharma, Research and Development

Keeping tabs on Covid-19: Cell and gene clinical trials advance despite Covid-19…

August 7, 2020

Via: Pharma IQ

As the pharma industry stands firm in its commitment to advance the sector to fight Covid-19, news has emerged from the European Commission who intend to streamline the development of therapies using genetically modified organisms to treat Covid-19. The governing […]

Industry, Pharma

FDA puts Merck’s heart failure drug on priority review track

July 17, 2020

Via: FierceBiotech

The FDA has granted priority review status to Merck’s vericiguat, teeing the Big Pharma to receive an approval decision early next year. Vericiguat, which Merck partnered on with Bayer in a $1 billion deal, will enter the increasingly congested heart […]

FDA, Industry, Pharma, Regulations

Side effects don’t stop FDA panel from backing GSK blood cancer drug

July 15, 2020

Via: Biopharma Dive

The BCMA protein has emerged as a target of interest in multiple myeloma because it is expressed on malignant cells but not on normal tissue. As a result, drugmakers have developed several different approaches to home in on BCMA-expressing cells, […]

Industry, Pharma

Recce Pharmaceuticals Adds Biotech Veteran Alan W. Dunton M.D. to its Board of Directors

July 14, 2020

Via: BioSpace

Recce Pharma Ltd (ASX: RCE) (Company), the Company developing new classes of synthetic anti-infectives, today announced the appointment of Alan W. Dunton, M.D., to its Board of Directors as an independent Non-Executive Director and as a member of the Company’s […]

Industry, News, Pharma

Nephron Pharmaceuticals Corporation Announces Historic Expansion in Lexington County

July 10, 2020

Via: BioSpace

One of the fastest-growing pharmaceuticals companies in the country, headquartered in Lexington County, today announced several major expansion and investment projects. Nephron Pharmaceuticals Corporation plans a new $215 million investment in Lexington County, bringing 380 new full-time jobs to the […]

Cell and Gene Therapy, Industry, News, Pharma

Peptide Drug Discovery Could Lead to a Powerful Anti-Inflammatory

July 2, 2020

Via: Genetic Engineering and Biotechnology News

Researchers at the University of Toronto’s Faculty of Dentistry and the National Jewish Health in Denver report a new drug discovery that could be useful to combat inflammation of all varieties and shows promise in fighting acute respiratory illnesses such […]

Industry, Manufacturing, Pharma, Research and Development

Molecular simulations show how drugs block key receptors

June 25, 2020

Via: ScienceDaily

G-protein-coupled receptors (GPCRs) are among the protein target groups of the greatest importance for drug development. These receptors react to, for example, light, flavours, smells, adrenaline, histamine, dopamine and a long list of other molecules by transmitting further biochemical signals […]

FDA, Industry, Pharma, Regulations, Vaccines

FDA Approves Drug to Treat Infants and Children with HIV

June 12, 2020

Via: BioSpace

Today, the U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination […]

Cell and Gene Therapy, Industry, Pharma

Using gene therapy to help the body to make its own cancer drugs

May 29, 2020

Via: Medical News

Imagine that we could instruct our bodies to make the drugs they need themselves. The gene technology that makes this possible is called mRNA therapy, which may become a major tool in the treatment of multiple diseases. Norwegian researchers are […]